Shandong Linuo Pharmaceutical Packaging Balance Sheet Health
Financial Health criteria checks 4/6
Shandong Linuo Pharmaceutical Packaging has a total shareholder equity of CN¥1.6B and total debt of CN¥388.9M, which brings its debt-to-equity ratio to 25%. Its total assets and total liabilities are CN¥2.2B and CN¥648.2M respectively. Shandong Linuo Pharmaceutical Packaging's EBIT is CN¥89.8M making its interest coverage ratio 30.2. It has cash and short-term investments of CN¥732.2M.
Key information
25.0%
Debt to equity ratio
CN¥388.91m
Debt
| Interest coverage ratio | 30.2x |
| Cash | CN¥732.16m |
| Equity | CN¥1.56b |
| Total liabilities | CN¥648.22m |
| Total assets | CN¥2.21b |
Recent financial health updates
Recent updates
Here's Why Shandong Linuo Technical GlassLtd (SZSE:301188) Can Manage Its Debt Responsibly
Oct 21
Shandong Linuo Technical Glass Co.,Ltd.'s (SZSE:301188) P/E Is Still On The Mark Following 34% Share Price Bounce
Oct 02Is There Now An Opportunity In Shandong Linuo Technical Glass Co.,Ltd. (SZSE:301188)?
Sep 28Shandong Linuo Technical GlassLtd's (SZSE:301188) Dividend Is Being Reduced To CN¥0.10
May 31Earnings Tell The Story For Shandong Linuo Technical Glass Co.,Ltd. (SZSE:301188) As Its Stock Soars 27%
May 21Be Wary Of Shandong Linuo Technical GlassLtd (SZSE:301188) And Its Returns On Capital
May 02Financial Position Analysis
Short Term Liabilities: 301188's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥237.4M).
Long Term Liabilities: 301188's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥410.9M).
Debt to Equity History and Analysis
Debt Level: 301188 has more cash than its total debt.
Reducing Debt: 301188's debt to equity ratio has increased from 15% to 25% over the past 5 years.
Debt Coverage: 301188's debt is not well covered by operating cash flow (13.2%).
Interest Coverage: 301188's interest payments on its debt are well covered by EBIT (30.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 00:26 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shandong Linuo Pharmaceutical Packaging Co., Ltd. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mingxin Sun | Citic Securities Co., Ltd. |
| Yang Huang | Industrial Securities Co. Ltd. |
| Yang Li | Minsheng Securities Co. |